The novel approach of this peptide represents a major development in the management of the condition. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide997653.59bloggers.com/42425810/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment